Peculiarities of changes in the coagulation and fibrinolytic activity in patients with coronary heart disease and concomitant type 2 diabetes mellitus, depending on the presence of diabetic vascular complications
Background. The purpose of this work was to study endogenous coagulation/fibrinolysis markers in patients with coronary heart disease (CHD) and concomitant type 2 diabetes mellitus (DM) and to compare these indices with respect to microvascular complications. Materials and methods. We have examined...
Main Author: | Yu.A. Zolotukhina |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2018-11-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/154852 |
Similar Items
-
Peculiarities of changes in anticoagulant and coagulant activity in patients with coronary artery disease combined with type 2 diabetes mellitus
by: Yu.O. Zolotukhina
Published: (2019-03-01) -
Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
by: Hidesaku Asakura, et al.
Published: (2020-09-01) -
Comparative characteristic of fibrinolytic activity in case of experimental peritonitis and underlying diabetes mellitus
by: F.V. Grynchuk, et al.
Published: (2017-11-01) -
Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
by: Auristela I. O. Ramos, et al.
Published: (2003-10-01) -
Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
by: Farwa Altaf, et al.
Published: (2021-05-01)